From Discovery to Delivery: Implementing Precision Oncology at Scale Precision medicine is no longer just a scientific capability, it is a systemic challenge that requires us to work at pace. We recently had the privilege of exploring this shift at the Asia-Pacific...
Insights from the Oxford Nanopore Sydney User Group The shift from scientific capability to clinical reality requires a community that leans in. We recently had the privilege of exploring this at the Oxford Nanopore Technologies (ONT) Sydney User Group Meeting, held...
Advancing Cell & Gene Therapies Together: Thank You from the Summit Precision medicine is no longer just a scientific capability; it is a systemic challenge that requires us to work at pace. We recently had the privilege of exploring this at the Cell & Gene...
Reflecting on Rare Disease Day This year’s global Rare Disease Day theme is “More than you can imagine,” and we are deeply grateful to have seen this vision brought to life at the recent GSNV Rare Disease Day event. We were honored to join leading patient advocates...
Congratulations to Omico on the launch of their 10 Year Impact Report It was a privilege to attend the launch of Omico’s 10-Year Impact Report at Parliament House, received by Minister Mark Butler, MP. The outcomes are nothing short of extraordinary. As the Minister...
InGeNA at AusBiotech 2025 What a week! We joined industry leaders at the AusBiotech International Conference 2025 for an energising few days of insight, connection, and momentum for precision medicine. Across formal sessions and informal conversations, there was a...
